Study Stopped
lack of recruitement
Effectiveness of UVA1-irradiation in the Treatment of Early Skin Fibrosis in Patients Suffering From Systemic Sclerosis
Multizenter-Studie Zur UVA-1 Therapie für Die Hautbeteiligung Bei Systemischer Sklerodermie
Sponsor study identifier
interventional
9
1 country
2
Study Start
February 2008
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
July 2010
Actual (reported)Study Completion
November 2013
Actual (reported)Systemic scleroderma (SSc) is a rare chronic inflammatory diseae of the connective tissue involving the skin and internal organs. To date there is no proven therapy for the skin fibrosis available. A number of case reports and small uncontrolled cohort studies suggest that UVA1 therapy may improve skin fibrosis. The aim of this study is therefore to investigate whether treatment UVA1 in deed is effective in treating skin fibrosis in SSc using a randomized, intraindividual half body irradiation protocol.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
November 2013
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
February 2008
Date type not reportedThis date has not been verified as actual or estimated.
February 26, 2008
Actual (reported)March 5, 2008
Actual (reported)July 2010
Actual (reported)November 2013
Actual (reported)modified skin score
3 months
modified skin score
6 months
histologic examination
3 months
half body irradiation with random allocation right and left; after three months of treatment treatment of both sides
intraindividual half body irradiation
60 J/cm2 at least 36 tx
University of Tuebingen, Dept. of Dermatology
Tübingen, Baden-Wurttemberg, 72076, Germany
University of Cologne, Dept. of Dermatology
Cologne, North Rhine-Westphalia, 50937, Germany
Nicolas Hunzelmann
University of Cologne, Dept. of Dermatology
9 participants (actual enrollment reported by the registry).
First Submitted
February 26, 2008
First Posted
March 5, 2008
Study Start
February 2008
Date type not reportedThis date has not been verified as actual or estimated.
Treprostinil Iontophoresis : a Pharmacodynamic and Pharmacokinetic Study
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Primary Completion
July 2010
Actual (reported)Study Completion
November 2013
Actual (reported)Last Updated
May 31, 2017
Record last verified: 2017-05
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: